• 1. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

• Solvents and Organic Chemicals Organic Compounds Organosulfur compounds Thioethers Aryl thioethers

Introduction to 2-4-(ethylsulfanyl)phenylacetic acid (CAS No. 3583-58-2)

2-4-(ethylsulfanyl)phenylacetic acid, identified by its Chemical Abstracts Service (CAS) number 3583-58-2, is a compound of significant interest in the field of pharmaceutical chemistry and bioorganic synthesis. This molecule, featuring a phenyl ring substituted with an ethylsulfanyl group and an acetic acid moiety, has garnered attention due to its structural versatility and potential biological activities. The presence of both sulfur and aromatic functionalities makes it a promising candidate for further exploration in drug discovery and material science applications.

The structural framework of 2-4-(ethylsulfanyl)phenylacetic acid consists of a benzene ring connected to an ethylsulfanyl group at the 2-position and an acetic acid side chain at the 4-position. This arrangement introduces both hydrophobic and hydrophilic regions, which can influence its solubility, reactivity, and interaction with biological targets. The ethylsulfanyl group, in particular, is known for its ability to participate in hydrogen bonding and metal coordination, making it a valuable moiety in designing molecules with specific binding properties.

In recent years, there has been growing interest in sulfur-containing heterocycles and their derivatives due to their diverse pharmacological profiles. 2-4-(ethylsulfanyl)phenylacetic acid falls within this category, and its potential applications have been explored in various therapeutic areas. For instance, studies have suggested that compounds with similar structural motifs may exhibit anti-inflammatory, antimicrobial, and anticancer properties. The phenylacetic acid scaffold is well-documented for its role in modulating biological pathways, particularly those involving neurotransmitter systems and lipid metabolism.

One of the most compelling aspects of 2-4-(ethylsulfanyl)phenylacetic acid is its synthetic accessibility. The compound can be readily prepared through established organic reactions such as sulfonylation followed by reduction or direct functionalization of the phenyl ring. This ease of synthesis allows researchers to modify the structure further, enabling the exploration of analogues with enhanced or tailored properties. For example, introducing additional substituents at different positions on the phenyl ring could alter the compound's bioavailability or target specificity.

Recent advancements in computational chemistry have also contributed to the study of 2-4-(ethylsulfanyl)phenylacetic acid. Molecular modeling techniques can predict how this compound interacts with biological targets at the atomic level, providing insights into its mechanism of action. Such simulations are particularly useful in identifying potential drug candidates before costly experimental trials. Moreover, virtual screening methods have been employed to identify novel derivatives of 2-4-(ethylsulfanyl)phenylacetic acid that may exhibit improved efficacy or reduced toxicity.

The pharmacological potential of 2-4-(ethylsulfanyl)phenylacetic acid has been investigated in several preclinical studies. Researchers have focused on its interaction with enzymes and receptors involved in inflammation and pain signaling. For instance, preliminary data suggest that derivatives of this compound may inhibit cyclooxygenase (COX) enzymes, which are key players in the production of prostaglandins—mediators of inflammation and pain. Additionally, the ethylsulfanyl group may enhance binding affinity to certain protein targets by improving hydrophobic interactions or hydrogen bonding capabilities.

In material science, 2-4-(ethylsulfanyl)phenylacetic acid has shown promise as a building block for designing functional materials. Its ability to form coordination complexes with transition metals makes it useful in catalysis and sensing applications. For example, metal complexes derived from this compound could serve as catalysts for organic transformations or as sensors for detecting small molecules in environmental samples. The versatility of its structure allows for further functionalization, enabling the creation of materials with specific electronic or optical properties.

The environmental impact of 2-4-(ethylsulfanyl)phenylacetic acid has also been considered in recent research. Studies have examined its degradation pathways under various conditions, assessing its persistence and potential toxicity in aquatic ecosystems. Understanding these environmental fate processes is crucial for evaluating the compound's overall safety profile and ensuring sustainable use in industrial applications. Efforts are ongoing to develop greener synthetic routes that minimize waste generation and reduce environmental footprint.

Future directions for research on 2-4-(ethylsulfanyl)phenylacetic acid include exploring its role in neurodegenerative diseases and developing novel therapeutic strategies based on its structural features. The phenylacetic acid moiety is known to interact with neurotransmitter systems such as serotonin and dopamine pathways, suggesting potential applications in treating conditions like Alzheimer's disease or Parkinson's disease. Additionally, modifications to the ethylsulfanyl group could enhance pharmacokinetic properties, leading to more effective drug formulations.

In conclusion,2-4-(ethylsulfanyl)phenylacetic acid (CAS No. 3583-58-2) is a multifunctional compound with broad applications across pharmaceutical chemistry, bioorganic synthesis, and material science. Its unique structural features—combining an aromatic ring with sulfur-containing functional groups—make it a valuable scaffold for drug discovery and material design. As research continues to uncover new possibilities for this molecule,2-4-(ethylsulfanyl)phenylacetic acid is poised to play a significant role in advancing scientific understanding and technological innovation.

• 16188-55-9(2-[4-(methylsulfanyl)phenyl]acetic acid)
• 18698-73-2(2-3-(methylsulfanyl)phenylacetic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)